BioNTech SE (BioNTech SE) Change In Inventory : $88 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is BioNTech SE Change In Inventory?

BioNTech SE's change in inventory for the quarter that ended in Dec. 2023 was $63 Mil. It means BioNTech SE's inventory declined by $63 Mil from Sep. 2023 to Dec. 2023 .

BioNTech SE's change in inventory for the fiscal year that ended in Dec. 2023 was $89 Mil. It means BioNTech SE's inventory declined by $89 Mil from Dec. 2022 to Dec. 2023 .

BioNTech SE's Total Inventories for the quarter that ended in Dec. 2023 was $390 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BioNTech SE's Days Inventory for the quarter that ended in Dec. 2023 was 194.76.

Inventory Turnover measures how fast the company turns over its inventory within a year. BioNTech SE's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioNTech SE's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.26.

BioNTech SE Change In Inventory Historical Data

The historical data trend for BioNTech SE's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Change In Inventory Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-6.44

-60.58

-495.37

66.63

89.31

BioNTech SE Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-153.39	16.60	-26.87	35.43	63.25

BioNTech SE Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $88 Mil.

BioNTech SE (NAS:BNTX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioNTech SE's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	416.863	/	195.311	*	365 / 4
	=	194.76

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioNTech SE's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	195.311	/	416.863
	=	0.47

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioNTech SE's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	416.863	/	1612.868
	=	0.26

BioNTech SE Change In Inventory Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE (BioNTech SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (NAS:BNTX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.